[{"arm_notes": "", "treatment_id": null, "treatment_name": "One hundred and eighty-five hemodialysis patients were vaccinated with 30 mg of BNT162b2 vaccine twice at 3-week intervals. Two weeks later; SARS-CoV-2 IgG antibodies were measured. Patients were also interviewed about adverse events of the vaccine.Controls were 109 health care workers who received two doses of 30 mg of BNT162b2 vaccine at 3-week intervals. Two weeks later; SARS-CoV-2 IgG antibodies were measured. They were also interviewed about adverse events of the vaccine.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "hemodialysis patients", "treatment_id": 222, "treatment_name": "Bnt162b2", "treatment_type": "Rna based vaccine", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "health care workers", "treatment_id": 222, "treatment_name": "Bnt162b2", "treatment_type": "Rna based vaccine", "pharmacological_treatment": "Vaccine"}]